Yao Lan, Graff J Carolyn, Aleya Lotfi, Ma Jiamin, Cao Yanhong, Wei Wei, Sun Shuqiu, Wang Congyi, Jiao Yan, Gu Weikuan, Wang Gang, Sun Dianjun
Department of Orthopedic Surgery and BME-Campbell Clinic, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
College of Nursing, University of Tennessee Health Science Center, Memphis, TN 38105, USA.
Trop Med Infect Dis. 2022 Sep 10;7(9):241. doi: 10.3390/tropicalmed7090241.
The greatest challenges are imposed on the overall capacity of disease management when the cases reach the maximum in each wave of the pandemic.
The cases and deaths for the four waves of COVID-19 in 119 countries and regions (CRs) were collected. We compared the mortality across CRs where populations experience different economic and healthcare disparities.
Among 119 CRs, 117, 112, 111, and 55 have experienced 1, 2, 3, and 4 waves of COVID-19 disease, respectively. The average mortality rates at the disease turning point were 0.036, 0.019. 0.017, and 0.015 for the waves 1, 2, 3, and 4, respectively. Among 49 potential factors, income level, gross national income (GNI) per capita, and school enrollment are positively correlated with the mortality rates in the first wave, but negatively correlated with the rates of the rest of the waves. Their values for the first wave are 0.253, 0.346 and 0.385, respectively. The r value for waves 2, 3, and 4 are -0.310, -0.293, -0.234; -0.263, -0.284, -0.282; and -0.330, -0.394, -0.048, respectively. In high-income CRs, the mortality rates in waves 2 and 3 were 29% and 28% of that in wave 1; while in upper-middle-income CRs, the rates for waves 2 and 3 were 76% and 79% of that in wave 1. The rates in waves 2 and 3 for lower-middle-income countries were 88% and 89% of that in wave 1, and for low-income countries were 135% and 135%. Furthermore, comparison among the largest case numbers through all waves indicated that the mortalities in upper- and lower-middle-income countries is 65% more than that of the high-income countries.
Conclusions from the first wave of the COVID-19 pandemic do not apply to the following waves. The clinical outcomes in developing countries become worse along with the expansion of the pandemic.
在疫情的每一波中,当病例数达到峰值时,疾病管理的整体能力面临最大挑战。
收集了119个国家和地区(CRs)四波新冠疫情的病例数和死亡数。我们比较了不同经济和医疗差距人群所在CRs的死亡率。
在119个CRs中,分别有117个、112个、111个和55个经历了1波、2波、3波和4波新冠疫情。各波疫情转折点的平均死亡率分别为:第1波0.036、第2波0.019、第3波0.017和第4波0.015。在49个潜在因素中,收入水平、人均国民总收入(GNI)和入学率与第1波的死亡率呈正相关,但与其余波次的死亡率呈负相关。它们在第1波中的值分别为0.253、0.346和0.385。第2波、第3波和第4波的r值分别为-0.310、-0.293、-0.234;-0.263、-0.284、-0.282;以及-0.330、-0.394、-0.048。在高收入CRs中,第2波和第3波的死亡率分别为第1波的29%和28%;而在中高收入CRs中,第2波和第3波的死亡率分别为第1波的76%和79%。中低收入国家第2波和第3波的死亡率分别为第1波的88%和89%,低收入国家为135%和135%。此外,对各波中最大病例数的比较表明,中高收入国家和低收入国家的死亡率比高收入国家高65%。
新冠疫情第一波得出的结论不适用于后续波次。随着疫情的蔓延,发展中国家的临床结果变得更糟。